Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram

@article{Kasper2009DifferencesIT,
  title={Differences in the dynamics of serotonin reuptake transporter occupancy may explain superior clinical efficacy of escitalopram versus citalopram},
  author={S. Kasper and J. Sacher and N. Klein and N. Mossaheb and Trawat Attarbaschi-Steiner and R. Lanzenberger and C. Spindelegger and S. Asenbaum and A. Holik and R. Dudczak},
  journal={International Clinical Psychopharmacology},
  year={2009},
  volume={24},
  pages={119-125}
}
  • S. Kasper, J. Sacher, +7 authors R. Dudczak
  • Published 2009
  • Psychology, Medicine
  • International Clinical Psychopharmacology
  • Escitalopram the S-enantiomer of the racemate citalopram, is clinically more effective than citalopram in the treatment of major depressive disorder. However, the precise mechanism by which escitalopram achieves superiority over citalopram is yet to be determined. It has been hypothesized that the therapeutically inactive R-enantiomer competes with the serotonin-enhancing S-enantiomer at a low-affinity allosteric site on serotonin reuptake transporters (SERTs), and reduces the effectiveness of… CONTINUE READING
    48 Citations
    Towards limiting QT interval prolongation and arrhythmia risk in citalopram use.
    • 1
    • PDF
    A comparative review of escitalopram, paroxetine, and sertraline: are they all alike?
    • 109
    • Highly Influenced
    Regional differences in SERT occupancy after acute and prolonged SSRI intake investigated by brain PET
    • 44
    Escitalopram plasma levels and antidepressant response
    • 16
    Stereo‐Psychopharmacology: The Case of Citalopram and Escitalopram
    • 2

    References

    SHOWING 1-10 OF 77 REFERENCES
    Higher serotonin transporter occupancy after multiple dose administration of escitalopram compared to citalopram: an [123I]ADAM SPECT study
    • 57
    Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    • 59
    • Highly Influential
    • PDF
    Escitalopram versus citalopram: the surprising role of the R-enantiomer
    • 219
    • Highly Influential
    In vivo imaging of serotonin transporter occupancy by means of SPECT and [123I]ADAM in healthy subjects administered different doses of escitalopram or citalopram
    • 68
    R-citalopram inhibits functional and 5-HTP-evoked behavioural responses to the SSRI, escitalopram
    • 56
    Efficacy comparison of escitalopram and citalopram in the treatment of major depressive disorder: pooled analysis of placebo-controlled trials.
    • 153
    • Highly Influential
    R‐citalopram functionally antagonises escitalopram in vivo and in vitro: evidence for kinetic interaction at the serotonin transporter
    • 56
    Serotonin transporter occupancy of five selective serotonin reuptake inhibitors at different doses: an [11C]DASB positron emission tomography study.
    • 399
    • Highly Influential
    • PDF